Betekenis van:
hepatitis c

hepatitis c
Zelfstandig naamwoord
    • a viral hepatitis clinically indistinguishable from hepatitis B but caused by a single-stranded RNA virus; usually transmitted by parenteral means (as injection of an illicit drug or blood transfusion or exposure to blood or blood products)

    Hyperoniemen


    Voorbeeldzinnen

    1. Hepatitis C
    2. HEPATITIS C
    3. (Hepatitis C virus)
    4. Detection of hepatitis C virus nucleic acid in serum
    5. Hepatitis C virus specific antibody response confirmed by a different antibody test
    6. Children of mothers with HIV, hepatitis B, hepatitis C or HTLV infection, or at risk of such infection, and who have not been breastfed by their mothers during the previous 12 months and for whom analytical tests, physical examinations, and reviews of medical records do not provide evidence of HIV, hepatitis B, hepatitis C or HTLV infection, can be accepted as donors.
    7. Purified antigens obtained from genetically manipulated yeast cells, for the manufacture of detection tests for hepatitis-C [1]
    8. Purified antigens obtained from genetically manipulated yeast cells, for the manufacture of detection tests for hepatitis C [1]
    9. History, clinical evidence, or laboratory evidence of HIV, acute or chronic hepatitis B (except in the case of persons with a proven immune status), hepatitis C and HTLV I/II, transmission risk or evidence of risk factors for these infections.
    10. where HIV 1 and 2, hepatitis B or hepatitis C test results are positive or unavailable, or where the donor is known to be a source of infection risk, a system of separate storage must be devised;
    11. Children aged less than 18 months born from mothers with HIV, hepatitis B, hepatitis C or HTLV infection, or at risk of such infection, and who have been breastfed by their mothers during the previous 12 months, cannot be considered as donors regardless of the results of the analytical tests.
    12. CTS for performance evaluation of reagents and reagent products for the detection, confirmation and quantification in human specimens of markers of HIV infection (HIV 1 and 2), HTLV I and II, and hepatitis B, C, D
    13. The clinical criteria of some diseases do not allude to the fact that many acute cases are asymptomatic, (e.g. hepatitis A, B and C, campylobacter, salmonellosis) although these cases may still be important from a public health perspective on national level.
    14. Reviewing the good practices in preventing drug-related blood-borne infectious diseases, in particular hepatitis (B/C), among injecting drug users to provide adequate guidance documents for practitioners and patients from different settings and vulnerable groups having taken into account an evaluation of the health, social, and economic impacts. [Financing mechanism: Call for proposals]
    15. CTS for the manufacturer’s release testing of reagents and reagent products for the detection, confirmation and quantification in human specimens of markers of HIV infection (HIV 1 and 2), HTLV I and II, and hepatitis B, C, D (Immunological assays only)